Iovance Biotherapeutics(DE:2LB)
€7.03-0.24 (-3.30%)
DE:2LB
Iovance Biotherapeutics earnings date
€7.03
At close:-0.24 (-3.30%)
Iovance Biotherapeutics (2LB) Q4 2021 Earnings Report
19 Followers
DE:2LB Q4 2021 EPS Results
- Actual EPS
- -EUR 0.56
- Consensus EPS
- -EUR 0.50
- Beat/Miss
- Missed by -EUR 0.06
- One Year Ago EPS
- -EUR 0.42
DE:2LB Q4 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/24/2022
- Time
- After Close
- Conference Call
- Thursday, February 24, 2022
DE:2LB Upcoming Earnings
Iovance Biotherapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2LB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.04- | -0.16 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.08-0.04 | -0.22 | 80.00% (+0.18) | |
| Aug 06, 2026 | 2026 (Q2) | -0.12-0.10 | -0.3 | 66.67% (+0.20) | |
| May 07, 2026 | 2026 (Q1) | -0.14-0.17 | -0.32 | 47.22% (+0.15) | |
| Feb 24, 2026 | 2025 (Q4) | -0.16-0.16 | -0.23 | 30.77% (+0.07) | |
| Nov 06, 2025 | 2025 (Q3) | -0.23-0.22 | -0.25 | 10.71% (+0.03) | |
| Aug 07, 2025 | 2025 (Q2) | -0.25-0.30 | -0.3 | 2.94% (+0.01) | |
| May 08, 2025 | 2025 (Q1) | -0.22-0.32 | -0.38 | 14.29% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.24-0.23 | -0.4 | 42.22% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -0.27-0.25 | -0.41 | 39.13% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
